or Try an Advanced Search...

    Technical Analysis for TNXP - Tonix Pharmaceuticals Holding Corp.

    Grade Last Price % Change Price Change
    F 0.14 -4.13% -0.01
    TNXP closed down 4.13 percent on Friday, November 1, 2024, on 40 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: Nov 7
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical TNXP trend table...
    Date Alert Name Type % Chg
    Stochastic Reached Oversold Weakness 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion -4.13%
    Down 3 Days in a Row Weakness -4.13%
    Fell Below 20 DMA Bearish -9.78%
    Outside Day Range Expansion -9.78%
    Older End-of-Day Signals for TNXP ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 23 hours ago
    Down 3% about 23 hours ago
    Down 2 % about 23 hours ago
    Down 1% about 23 hours ago
    Up 5% 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    TNXP Chart by TradingView
    Basic chart:

    Profile

    Tonix Pharmaceuticals Holding Corp., a development stage specialty pharmaceutical company, focuses on the development of pharmaceutical products for the disorders of central nervous system. The company's lead product candidate includes TNX-102 SL, a dose and formulation of cyclobenzaprine for the treatment of fibromyalgia and post-traumatic stress disorder. It also has a pipeline of various other product candidates, including TNX-201, which is a treatment for certain types of headaches; and TNX-301. The company was founded in 2007 and is headquartered in New York, New York.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Sciences Drugs Pharmaceutical Products Disorders Post Traumatic Stress Disorder Headache Stage Specialty Pharmaceutical Fibromyalgia Seth Lederman

    Is TNXP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 1 Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024
    Oct 29 Tonix Pharmaceuticals to Present at BIO-Europe® 2024
    Oct 25 Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference
    Oct 24 Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024
    Oct 22 (TNXP) - Analyzing Tonix Pharmaceuticals's Short Interest
    Oct 17 Tonix stock climbs 6% on first payment under $34M DOD contract
    Oct 17 Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA)
    Oct 16 Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals
    Oct 16 Tonix Pharmaceuticals announces submission of NDA for non-opioid analgesic
    Oct 16 Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA)
    See more TNXP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.1376
    52 Week Low 0.118
    Average Volume 30,030,338
    200-Day Moving Average 4.22
    50-Day Moving Average 0.17
    20-Day Moving Average 0.16
    10-Day Moving Average 0.17
    Average True Range 0.02
    RSI (14) 38.65
    ADX 21.79
    +DI 26.48
    -DI 23.07
    Chandelier Exit (Long, 3 ATRs) 0.14
    Chandelier Exit (Short, 3 ATRs) 0.19
    Upper Bollinger Bands 0.19
    Lower Bollinger Band 0.13
    Percent B (%b) 0.19
    BandWidth 40.15
    MACD Line -0.01
    MACD Signal Line -0.01
    MACD Histogram 0.0019
    Fundamentals Value
    Market Cap 8.17 Million
    Num Shares 58.6 Million
    EPS -9.26
    Price-to-Earnings (P/E) Ratio -0.02
    Price-to-Sales 4.85
    Price-to-Book 0.16
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.17
    Resistance 3 (R3) 0.17 0.16 0.16
    Resistance 2 (R2) 0.16 0.15 0.16 0.16
    Resistance 1 (R1) 0.15 0.15 0.15 0.15 0.16
    Pivot Point 0.14 0.14 0.14 0.14 0.14
    Support 1 (S1) 0.13 0.14 0.13 0.13 0.12
    Support 2 (S2) 0.13 0.13 0.12 0.12
    Support 3 (S3) 0.11 0.13 0.12
    Support 4 (S4) 0.11